Prevention of cytomegalovirus in organ transplant recipients: cross roads between antiviral and antitumor immunity.
Singh
Nina
N
Department of Medicine, Division of Infectious Diseases, Pittsburgh VA Healthcare System, Pittsburgh, PA, USA. nis5@pitt.edu
D000998:Antiviral Agents / Q000627:therapeutic use*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D011183:Postoperative Complications / Q000517:prevention & control / Q000821:virology*; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014181:Transplantation Immunology; D019737:Transplants / Q000009:adverse effects*
D000998:Antiviral Agents